LOS ANGELES, Nov. 6th, 2017 /PRNewswire/ — Glutenostics LLC formally announced today the launch of their first product line, Gluten Detect, a rapid test suite for people on the gluten-free diet (GFD) to monitor compliance. In just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days. “This revolutionary and one-of-a-kind technology will empower people to take control of their gluten-free life and improve adherence to the diet through scientifically informed decision making,” states David Winternheimer, PhD, CEO of Glutenostics. “Whatever your motive for maintaining gluten-free living, Gluten Detect is a flexible monitoring tool to provide valuable insight into your dietary composition, and afford users peace of mind.”
The technology basis of Gluten Detect was developed by a company in Seville, Spain (Biomedal), where over a decade of research and development was invested in the innovation of these game-changing products. As an integral part of the worldwide roll-out of both lab- and home-based testing products for gluten, Glutenostics is responsible for the commercialization of these tests in the USA and Canada, where they are the exclusive licensee and distributor of the technology.
“Glutenostics is transforming the way people live gluten-free,” states Dr. Winternheimer, “both with these novel tests and assessment of future product opportunities in our pipeline.” In collaboration with industry-leading key opinion leaders and non-profit partners, Glutenostics is working to change the landscape of the gluten-free space. “Today we are also proud to announce our new investor, cited as the most successful biotech entrepreneur in Germany, Patrick Baeuerle. With our outstanding team of advisors, executives and partners, we are optimistic of Glutenostics’ ability to positively impact the gluten-free community.”
About Glutenostics LLC
Glutenostics was founded in 2016 with the mission of bringing new technologies to market that improve the livelihood of those living gluten-free, regardless of reason. In 2017, Glutenostics licensed their first technology from Biomedal (Seville, Spain), and developed their first product line, Gluten Detect, now available exclusively via their website www.glutendetect.us. As Glutenostics continues to grow and expand, it continues to pursue partnerships with other technology innovators in the gluten-free and surrounding space to commercialize those products in North America.